Intraosseous administration into the skull: Potential blood–brain barrier bypassing route for brain drug delivery
Abstract Progress in treating central nervous system (CNS) disorders is retarded owing to a limited understanding of brain disease pathology. Additionally, the blood–brain barrier (BBB) limits molecular entry into the brain. Many approaches for brain drug delivery to overcome the BBB, such as BBB pe...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wiley
2023-03-01
|
| Collection: | Bioengineering & Translational Medicine |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1002/btm2.10424 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|